PMID: 9523610Apr 2, 1998Paper

Further clinical experience in permanent lip augmentation using autologous breast implant capsule

Annals of Plastic Surgery
J S Isenberg

Abstract

Lip augmentation is a well tolerated procedure that can lead to a more youthful appearance. Autologous tissue offers the safest and most long lasting results. Recently, a new source of autologous tissue, breast implant capsule, was described in the performance of permanent lip augmentation. Long term data in thirteen patients is presented and documents persistence of volume enhancement of over one year postoperatively.

Citations

Jul 2, 2009·Plastic and Reconstructive Surgery·Rod J Rohrich, Joel E Pessa
Apr 26, 2014·Aesthetic Plastic Surgery·Paolo PersichettiGiovanni Francesco Marangi
Apr 17, 2012·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Bassem M Mossaad, James D Frame
Jun 4, 2002·British Journal of Plastic Surgery·Francesco GarganoPeter M Arnstein
Jan 10, 2002·Otolaryngologic Clinics of North America·Stephen J Wall, Peter A Adamson
Nov 3, 2010·Annals of Plastic Surgery·Brian P DickinsonMalcolm A Lesavoy
Aug 2, 2007·The Journal of Craniofacial Surgery·Cassidy MitchellSeth R Thaller
Mar 2, 2006·Annals of Plastic Surgery·Seung-Kyu HanWoo-Kyung Kim
Jan 11, 2019·The American Journal of Tropical Medicine and Hygiene·Viravarn LuviraYupaporn Wattanagoon
May 19, 2005·Annals of Plastic Surgery·Danish ImranKaka Hama Attar
Apr 7, 2007·The Pediatric Infectious Disease Journal·Ladaporn BodhidattaCarl Jeffries Mason
Sep 15, 2007·Journal of Gastroenterology and Hepatology·Farid H Abu ElamreenJamal Elshikh Deeb
Jun 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MithoeA V M Möller
Dec 20, 2008·The Journal of International Medical Research·N YigitA Ayyildiz
Jul 15, 2015·The Journal of Craniofacial Surgery·Deok-Yeol KimWoo-Kyung Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.